Incannex Healthcare Inc. SEC filings IXHL
Incannex Healthcare Inc. has 266 filings in SEC EDGAR's recent list, going back to Aug 17, 2021. Its latest annual report, Form ARS, was filed on Oct 28, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Oct 28, 2026 | Jun 30, 2026 |
| 10-K | Annual report | Sep 25, 2026 | Jun 30, 2026 |
| ARS | Annual report to shareholders | Oct 27, 2025 | Jun 30, 2025 |
| 10-K | Annual report | Sep 29, 2025 | Jun 30, 2025 |
| ARS | Annual report to shareholders | Nov 12, 2024 | Jun 30, 2024 |
| 10-K | Annual report | Sep 30, 2024 | Jun 30, 2024 |
| 20-F | Annual report (foreign issuer) | Oct 31, 2023 | Jun 30, 2023 |
| 20-F | Annual report (foreign issuer) | Oct 28, 2022 | Jun 30, 2022 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IXHL (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Norwest Nsw
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1873875
- Former names
- Incannex Healthcare Ltd (until Nov 29, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.